Montana HDG is probably the best on this board to answer your question .
I'll take a stab at it ....based on what I remember . End of last Qt Cash on hand was around $600m ....this will be updated when they report Q2
The Co was close to break even at end of Q1 ....and talked about spending $70m on DTC .
Even with declining script numbers over the past month and DTC spending ...Co will still have plenty of $ to get thru the appeals court decision in 2021......but unlikely to be able to afford a GIA effort in the EU without a capital raise JMO Kiwi
If we can stabilize scrips in the mid or low 80k's they'll have plenty of cash as long as they don't go hog wild on DTC spending - don't forget that RSUs (and options?) cost them no cash, but count as losses on the books, something like $31M for 2019, but that just affects GAAP EPS.